Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  06/29/2005
 
Trade Name:  Topamax Tablets and Sprinkle Capsules
 
Generic Name or Proper Name (*):  topiramate
 
Indications Studied:  Initial monotherapy for partial onset or primary generalized tonic-clonic seizures in children 10 years of age and older
 
Label Changes Summary:  Effectiveness established in studies of patients down to 6 years of age Use in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials Provides information regarding treatment-emergent decrease in serum bicarbonate and adverse events Some patients in the study discontinued therapy due to adverse events; however, adverse events associated with discontinuing therapy included difficulty with concentration/attention Studies waived in children 0-2 years of age; deferred in children 2-10 years of age New indication
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Johnson & Johnson
 
NNPS:  FALSE'
 
Therapeutic Category:  Anticonvulsant
 
-
-